Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression

Recently Approved and Upcoming Treatments for Narcolepsy

(2020) Michael J. Thorpy   CNS DRUGS

Prevalence of Depression or Depressive Symptoms in Patients with Narcolepsy: a Systematic Review and Meta-Analysis

(2020) Xiao Li et al.   NEUROPSYCHOLOGY REVIEW

Clinical depression in untreated Obstructive Sleep Apnea: examining predictors and a meta-analysis of prevalence rates

(2019) Melinda L. Jackson et al.   SLEEP MEDICINE

Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline

(2019) Susheel P. Patil et al.   Journal of Clinical Sleep Medicine

A randomized study of solriamfetol for excessive sleepiness in narcolepsy

(2019) Michael J. Thorpy et al.   ANNALS OF NEUROLOGY

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3): A Randomized Controlled Trial

(2018) Paula K. Schweitzer et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effects of Antidepressants on Sleep

(2017) Adam Wichniak et al.   Current Psychiatry Reports

Obstructive sleep apnea (OSA) and clinical depression—prevalence in a sleep center

(2016) Jens Acker et al.   Sleep and Breathing

Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure

(2013) Merce Gasa et al.   JOURNAL OF SLEEP RESEARCH

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study

(2009) J-L. Pepin et al.   EUROPEAN RESPIRATORY JOURNAL